PACS Group, Inc. Stock: price and management transactions · United States · SEC (Form 4)

About PACS Group, Inc.

PACS Group, Inc. is a U.S.-listed healthcare company traded on the New York Stock Exchange (NYSE) under the ticker PACS, and it is based in the United States. For French-speaking investors, the company should be viewed as a post-acute care and senior housing platform rather than a pure real estate or generic healthcare name. Founded in 2013, PACS began with just two skilled nursing facilities and has since scaled into one of the largest post-acute operators in the United States, with more than 300 affiliated facilities across 17 states. Its corporate headquarters is in Salt Lake City, Utah. The company’s business model combines facility operations with centralized support services. PACS is primarily focused on skilled nursing facilities, while also participating in senior living, including assisted living and independent living, as well as rehabilitation and memory care services. Through its support platform, PACS Services, the company provides administrative and operational functions such as accounting, finance, human resources, payroll, information technology, compliance, legal, risk management, and corporate communications. This structure is designed to let local facility leadership focus on care delivery while benefiting from centralized scale, systems, and compliance oversight. From a competitive standpoint, PACS emphasizes its geographic density, scale, and ability to integrate facilities efficiently. Management describes the company as one of the largest skilled nursing providers in the United States by number of facilities. That scale matters in a highly regulated, labor-intensive industry because it can improve referral relationships with hospitals and health systems, support operating leverage, and enhance the company’s ability to absorb and improve underperforming assets. The platform’s expanded footprint also gives it a broader base for occupancy recovery, clinical mix improvement, and operational optimization. Recent developments have been constructive. PACS reported first-quarter 2026 results showing solid revenue growth and stronger profitability, and it raised its 2026 Adjusted EBITDA outlook. The company also continued to execute on acquisitions and portfolio expansion, ending the first quarter of 2026 with 324 healthcare operations across 17 states. In May 2026, the board also approved a $250 million share repurchase authorization, underscoring management’s confidence in the business and capital structure. For investors, PACS offers exposure to U.S. demographic tailwinds tied to an aging population, but it also carries the typical risks of post-acute care: reimbursement pressure, regulatory scrutiny, staffing costs, and execution risk in integration. Overall, it is a scaled, growth-oriented post-acute care platform with a strong operating focus and a clearly defined expansion strategy.